Skip to search formSkip to main contentSkip to account menu

Bretschneider cardioplegic solution

Known as: histidine-tryptophan-ketoglutarate solution, HTK solution, Bretschneider solution 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
AIM The aim of this paper was to improve operative outcome during open-heart surgery in patients with failing hearts, the… 
2004
2004
Background. Non–heart-beating donors (NHBDs) have the potential to reduce the increasing numbers of patients on kidney and liver… 
1999
1999
The purpose of this study was to assess the potential of preservation solutions for protecting skeletal muscle function during… 
1995
1995
Rat hearts were preserved for 18 hr under totally ischemic storage conditions at 0–1°C with the commercially supplied EuroCollins… 
Review
1993
Review
1993
Pharmacologic cardioplegia was not used widely in the United States until the past fifteen years because of previous reports of… 
1988
1988
The first clinical use of Bretschneider's HTK-solution for in-situ-protection of the kidney in mild hypothermia is reported. By…